What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman

(47:52)

New study reveals why patients stop taking GLP-1 obesity drugs

(3:45)

GLP-1 Agonists: Wonder Drugs of the 21st Century?

(50:30)

Expert Insights on GLP-1: Transforming Obesity \u0026 Diabetes Management [NEW]

(45:31)

What is GLP-1 \u0026 How Does It Reduce Appetite \u0026 Promote Weight Loss? | Dr. Andrew Huberman

(6:50)

Understanding risks of GLP-1 weight loss drugs

(4:56)

The Truth About GLP-1 for Weight Loss: Science \u0026Affordable Access Part 2

(51:38)

Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024

(1:7:25)

The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management

(58:16)

Prescribing GLP-1 Receptor Agonists for Weight Loss

(9:31)

Endocrinologist Explains The GLP-1 Rewind Study

(4:25)

75th Scientific Sessions: GLP-1 Alters How the Brain Responds to Food

(3:11)

Ian de Boer, MD, MS - GLP-1 Receptor Agonists for Patient with Kidney Disease

(31:29)

Weight loss drugs and addiction: Study shows GLP-1 may help reduce overdose risks

(2:31)

GLP 1 Agonists, Like Ozempic and Wegovy Linked to Gastrointestinal Risks : Study

(2:16)

“If the goal is to keep insulin low, why is GLP-1 good, since it stimulates insulin production?”

(3:22)

What Science ACTUALLY Says About Ozempic / Wegovy / Zepbound for Arthritis

(8:1econd)

*new study* GLP-1 FATTY LIVER DISEASE // ZEPBOUND WEIGHT LOSS \u0026 WEGOVY W/ GLP 1 AND FATTY LIVER

(18:57)

New study finds GLP-1 drugs lower risk of certain cancers

(3:15)

Glucagon-like Peptide (GLP-1) - Diabetes Treatment - Semaglutide (Ozempic), (Wegovy)

(4:2)